effects of glp 1 GLP-1/glucagon receptor co-agonism for treatment obesity | Diabetologia Systemic effects of tirzepatide dually

Pricing as of March 2026

doi:10.1073/pnas.89.1.251

Ships from Chattanooga, TN

Generation 2 Dual agonist (GLP-1 + GIP): Tirzepatide (sold as Mounjaro for diabetes and Zepbound for weight loss) targets two receptors: GLP-1 and GIP

It has a long-standing place in veterinary conversations about certain forms of cardiomyopathy and nutritional heart support

The first: if your PCOS presentation is inflammation-driven you have an autoimmune overlay, your inflammatory markers run high, you suspect gut permeability is part of what is going on NAC's antioxidant and anti-inflammatory mechanism is more directly relevant to your specific picture, and a NAC adjunct on top of the better-evidenced foundation is defensible